{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:18:52Z","timestamp":1791458332846,"version":"4.3.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05178-1","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:04:53Z","timestamp":1778076293000},"page":"4131-4138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Alignment between AI clinical decision tools and\u00a0multidisciplinary tumor board decisions in prostate cancer"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9780-9732","authenticated-orcid":false,"given":"Akif","family":"Koc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3492-8467","authenticated-orcid":false,"given":"Oguzhan","family":"Akpinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1589-322X","authenticated-orcid":false,"given":"Alper","family":"Keskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6835-9386","authenticated-orcid":false,"given":"Halil Ibrahim","family":"Tarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7249-4332","authenticated-orcid":false,"given":"Muhammet","family":"Guzelsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"5178_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11523-022-00925-7","volume":"17","author":"ND Shore","year":"2022","unstructured":"Shore ND, Morgans AK, El-Haddad G, Srinivas S, Abramowitz M (2022) Addressing challenges and controversies in the management of prostate cancer with multidisciplinary teams. Target Oncol 17:709\u2013725. https:\/\/doi.org\/10.1007\/s11523-022-00925-7","journal-title":"Target Oncol"},{"key":"5178_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000500426","volume":"42","author":"A Heidenreich","year":"2019","unstructured":"Heidenreich A (2019) Multidisciplinary team meetings for prostate cancer treatment: we can do much better in daily life. Oncol Res Treat 42:363\u2013365. https:\/\/doi.org\/10.1159\/000500426","journal-title":"Oncol Res Treat"},{"key":"5178_CR3","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3892\/ol.2017.7506","volume":"15","author":"A Colasante","year":"2018","unstructured":"Colasante A, Augurio A, Basilico R, Cotroneo A, Di Sciascio M, Gaspari G et al (2018) A multidisciplinary group for prostate cancer management: a single institution experience. Oncol Lett 15:1823\u20131828. https:\/\/doi.org\/10.3892\/ol.2017.7506","journal-title":"Oncol Lett"},{"key":"5178_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13182254","volume":"13","author":"I Dogan","year":"2025","unstructured":"Dogan I, Bartin MK, Sonmez E, Seyran E, Bozkurt HA, Yuksek M et al (2025) Chat GPT performance in multi-disciplinary boards: should AI be a member of cancer boards? Healthcare 13:2254. https:\/\/doi.org\/10.3390\/healthcare13182254","journal-title":"Healthcare"},{"key":"5178_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/pros.22904","volume":"75","author":"D Sundi","year":"2015","unstructured":"Sundi D, Cohen JE, Cole AP, Neuman BP, Cooper J, Faisal FA et al (2015) Establishment of a new prostate cancer multidisciplinary clinic: format and initial experience. Prostate 75:191\u2013199. https:\/\/doi.org\/10.1002\/pros.22904","journal-title":"Prostate"},{"key":"5178_CR6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.5108","volume":"43","author":"U Ayub","year":"2025","unstructured":"Ayub U, Naqvi SAA, Jajja SA, Afzal MU, Yum J-EI, Khakwani KZR et al (2025) A large language model (LLM)-based multi-agent framework for risk stratification and treatment recommendations in localized prostate cancer (locPCa). J Clin Oncol 43:5108. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.5108","journal-title":"J Clin Oncol"},{"key":"5178_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1268915","volume":"13","author":"GM Iannantuono","year":"2023","unstructured":"Iannantuono GM, Bracken-Clarke D, Floudas CS, Roselli M, Gulley JL, Karzai F (2023) Applications of large language models in cancer care: current evidence and future perspectives. Front Oncol 13:1268915. https:\/\/doi.org\/10.3389\/fonc.2023.1268915","journal-title":"Front Oncol"},{"key":"5178_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41746-025-01824-7","volume":"8","author":"Y Hao","year":"2025","unstructured":"Hao Y, Qiu Z, Holmes J, L\u00f6ckenhoff CE, Liu W, Ghassemi M et al (2025) Large language model integrations in cancer decision-making: a systematic review and meta-analysis. npj Digit Med 8:450. https:\/\/doi.org\/10.1038\/s41746-025-01824-7","journal-title":"npj Digit Med"},{"key":"5178_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-024-02459-6","volume":"24","author":"Y-J Park","year":"2024","unstructured":"Park Y-J, Pillai A, Deng J, Guo E, Gupta M, Paget M et al (2024) Assessing the research landscape and clinical utility of large language models: a scoping review. BMC Med Inform Decis Mak 24:72. https:\/\/doi.org\/10.1186\/s12911-024-02459-6","journal-title":"BMC Med Inform Decis Mak"},{"key":"5178_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41391-024-00826-y","volume":"28","author":"JS Hershenhouse","year":"2025","unstructured":"Hershenhouse JS, Mokhtar D, Eppler MB, Rodler S, Storino Ramacciotti L, Ganjavi C et al (2025) Accuracy, readability, and understandability of large language models for prostate cancer information to the public. Prostate Cancer Prostatic Dis 28:394\u2013399. https:\/\/doi.org\/10.1038\/s41391-024-00826-y","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5178_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajur.2025.06.003","volume":"13","author":"M Longoni","year":"2026","unstructured":"Longoni M, Zaurito P, Scilipoti P, Quarta L, Barletta F, Scuderi S, Stabile A et al (2026) Decision regret after robot-assisted radical prostatectomy: a systematic review and meta-analysis. Asian J Urol 13:1\u201310. https:\/\/doi.org\/10.1016\/j.ajur.2025.06.003","journal-title":"Asian J Urol"},{"key":"5178_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01103-4","volume":"9","author":"IC Wiest","year":"2025","unstructured":"Wiest IC, Wolf F, Le\u00dfmann M-E, van Treeck M, Ferber D, Zhu J et al (2025) A software pipeline for medical information extraction with large language models, open source and suitable for oncology. npj Precis Oncol 9:313. https:\/\/doi.org\/10.1038\/s41698-025-01103-4","journal-title":"npj Precis Oncol"},{"key":"5178_CR13","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.annonc.2025.09.001","volume":"36","author":"EYT Wong","year":"2025","unstructured":"Wong EYT, Verlingue L, Aldea M, Franzoi MA, Umeton R, Halabi S et al (2025) ESMO guidance on the use of large language models in clinical practice (ELCAP). Ann Oncol 36:1447\u20131457. https:\/\/doi.org\/10.1016\/j.annonc.2025.09.001","journal-title":"Ann Oncol"},{"key":"5178_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.37349\/etat.2023.00160","volume":"4","author":"B Farasati Far","year":"2023","unstructured":"Farasati Far B (2023) Artificial intelligence ethics in precision oncology: balancing advancements in technology with patient privacy and autonomy. Explor Target Antitumor Ther 4:685\u2013689. https:\/\/doi.org\/10.37349\/etat.2023.00160","journal-title":"Explor Target Antitumor Ther"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05178-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05178-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05178-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:53:11Z","timestamp":1789631591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05178-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":14,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5178"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05178-1","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Ethical approval was obtained from the Regional Ethics Committee (Approval No: 2024-TBEK 2026\/01-12; Date: January 28, 2026). The study analyzed previously discussed multidisciplinary tumor board cases using fully anonymized clinical data. Due to the retrospective nature of the study, the requirement for informed consent was waived by the ethics committee.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the ESMO guidance on the use of Large Language Models in Clinical Practice, the authors declare that AI-assisted tools were utilized solely for linguistic refinement, structural organization, and citation management of the manuscript [\n                      \n                      ]. All scientific content, data analysis, and clinical interpretations were produced, reviewed, and approved by the human authors, who remain fully responsible for the integrity of the work.","order":3,"name":"Ethics","label":"Use of AI in scientific writing","group":{"name":"EthicsHeading","label":"Declarations"}}]}}